Ihab Ibrahim Soliman, M.D.
NPI 1851594212ActiveIndividual· Psychiatry & Neurology, Child & Adolescent Psychiatry· Corona Del Mar, CA
Opted out of Medicare from December 2017 to December 2027. Psychiatry & Neurology, Child & Adolescent Psychiatry (M.D.) in Corona Del Mar, California, licensed in CA, with an NPI issued in June 2007. Part D covered 1,044 prescriptions written in 2024, 86% of them generic. Supernus Pharmaceuticals, Inc. was the largest of 14 companies reporting payments in 2025, $21,917 in all, mostly honoraria.
Overview
| NPI | 1851594212 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Jun 5, 2007 |
| Last updated in NPPES | Jun 20, 2024 |
| Certified by provider | Jun 20, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Psychiatry & Neurology, Child & Adolescent Psychiatry Primary | 2084P0804X | A048206 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Dec 5, 2017 – Dec 5, 2027 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 1,044 · 1,556 30-day fills |
|---|---|
| Patients | 75 |
| Total drug cost | $125,589 |
| Generic share | 86% of claims |
Industry payments (Open Payments)
- 2025$21,917 · 129 payments from 14 companies
- 2024$13,055 · 134 payments from 13 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $19,915 | 33 |
| Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) | $448.85 | 24 |
| Tris Pharma Inc | $415.46 | 20 |
| Alkermes, Inc. | $314.56 | 11 |
| Corium, LLC | $198.89 | 11 |
What the 2025 payments were for
- Honoraria$17,675 · 9 payments
- Food and Beverage$2,504 · 113 payments
- Travel and Lodging$1,738 · 7 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records